Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kids' Allergy
- Development stage
- Unknown
- Lead developer
- Genexa
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kids' Allergy is an over-the-counter (OTC) liquid antihistamine developed and marketed by Genexa. It is formulated as a "clean" medicine, meaning it contains the active ingredient diphenhydramine hydrochloride but is free from artificial inactive ingredients, such as artificial dyes, preservatives, sweeteners, and common allergens. Instead, it is flavored with organic agave syrup. Kids' Allergy is indicated for the temporary relief of symptoms associated with hay fever or other upper respiratory allergies, including runny nose, sneezing, itchy nose or throat, and itchy, watery eyes, in children aged 6 years and older.
- Brand names
- Kids' Allergy
02
Targets
HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on Kids' Allergy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kids' Allergy.